Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute myocardial infarction.

Harvey D White1, Derek P Chew

  • 1Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.

Lancet (London, England)
|August 19, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiography-Derived Index of Microcirculatory Resistance (Angio-IMR) Is Associated With Doppler-Derived Hyperemic Microvascular Resistance.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Implementation of Evidence-Based, Person-Centered Alternative Delivery Models for Cardiac Rehabilitation in a Rural and Remote Population: The Country Heart Attack Prevention (CHAP) Project.

Heart, lung & circulation·2026
Same author

Characteristics, readmission patterns and trends in hospitalisations for chronic coronary disease in Western Australia, 2005 to 2022.

International journal of cardiology·2026
Same author

Allergy-Associated Acute Coronary Syndromes: Therapeutic Framework for Kounis Syndrome.

JACC. Case reports·2026
Same author

Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial.

European heart journal·2026
Same author

Beta-blocker therapy and all-cause mortality after a coronary event: A matched nested case-control study using the Victorian Cardiac Outcomes Registry linked data.

Current problems in cardiology·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Modern acute myocardial infarction (MI) management has significantly reduced mortality through antithrombotic therapy and timely reperfusion. Challenges remain in applying evidence to all patients and addressing global cardiovascular disease trends.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Evidence-Based Practice

Background:

  • Acute myocardial infarction (MI) management has evolved over 30 years, significantly reducing mortality and morbidity.
  • Success relies on integrating antithrombotic therapy with timely reperfusion strategies (PCI or fibrinolysis for STEMI; invasive care for NSTEMI).
  • Risk stratification and optimized care systems are crucial for effective MI management.

Purpose of the Study:

  • To discuss the pathophysiology, diagnosis, risk stratification, and management of myocardial infarction.
  • To highlight the evolution of MI care based on clinical evidence.
  • To address challenges in translating evidence to diverse patient populations and global health trends.

Main Methods:

  • Review of clinical evidence from studies over the past three decades.

Related Experiment Videos

  • Analysis of diagnostic advancements, including troponin assays and the universal definition of MI.
  • Discussion of therapeutic strategies, including antithrombotic therapy, reperfusion, and revascularization.

    • Main Results:

    • Substantial reduction in mortality and morbidity associated with acute MI.
    • Improved understanding of MI pathophysiology through troponin assays and universal classification.
    • Emerging awareness of adverse events like bleeding and disparities in care.

    Conclusions:

    • Effective MI management integrates antithrombotic therapy with timely reperfusion and risk stratification.
    • Challenges include equitable evidence translation for underrepresented groups (elderly, renal failure) and global health shifts.
    • Future demands on healthcare systems will increase due to diabetes, obesity, and the rise of cardiovascular disease in developing nations.